Acutus Medical, Inc.
NASDAQ:AFIB
0.042 (USD) • At close April 2, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 Q4 | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | 2019 Q4 | 2019 Q3 | 2019 Q2 | 2019 Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 7.139 | 5.266 | 4.127 | 3.625 | -7.532 | 5.238 | 5.289 | 1.242 | 4.962 | 3.644 | 4.076 | 3.681 | 4.362 | 4.601 | 4.709 | 3.591 | 2.574 | 3.173 | 1.134 | 1.583 | 0.669 | 0.646 | 0.734 | 0.787 |
| Cost of Revenue
| 6.125 | 4.894 | 4.47 | 3.655 | -13.146 | 8.595 | 8.063 | 2.111 | 8.321 | 6.951 | 9.697 | 6.941 | 9.939 | 8.539 | 7.492 | 6.955 | 4.891 | 5.141 | 2.663 | 3.194 | 2.365 | 2.267 | 2.435 | 2.176 |
| Gross Profit
| 1.014 | 0.372 | -0.343 | -0.03 | 5.614 | -3.357 | -2.774 | -0.869 | -3.359 | -3.307 | -5.621 | -3.26 | -5.577 | -3.938 | -2.783 | -3.364 | -2.317 | -1.968 | -1.529 | -1.611 | -1.696 | -1.621 | -1.701 | -1.389 |
| Gross Profit Ratio
| 0.142 | 0.071 | -0.083 | -0.008 | -0.745 | -0.641 | -0.524 | -0.7 | -0.677 | -0.908 | -1.379 | -0.886 | -1.279 | -0.856 | -0.591 | -0.937 | -0.9 | -0.62 | -1.348 | -1.018 | -2.535 | -2.509 | -2.317 | -1.765 |
| Reseach & Development Expenses
| 0 | 0 | 0 | 0 | -14.23 | 4.795 | 6.799 | 0.938 | 6.269 | 5.946 | 7.935 | 8.003 | 8.84 | 9.299 | 9.174 | 9.37 | 8.962 | 8.343 | 8.176 | 7.973 | 7.54 | 20.865 | 5.247 | 4.377 |
| General & Administrative Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 15.164 | 15.833 | 9.125 | 10.235 | 7.849 | 7.978 | 6.927 | 4.093 |
| Selling & Marketing Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -10.235 | 0 | 0 | 10.235 | 0 | 0 | 0 | 4.093 |
| SG&A
| 2.556 | 2.318 | 2.225 | 3.337 | -12.214 | 7.432 | 9.284 | 4.472 | 9.447 | 9.679 | 14.143 | 14.385 | 15.865 | 15.805 | 15.601 | 16.252 | 15.164 | 15.833 | 9.125 | 10.235 | 7.849 | 7.978 | 6.927 | 4.093 |
| Other Expenses
| -6.931 | -2.435 | 0 | 0 | 0 | 0 | 0 | -1.007 | 0 | 1.529 | 0 | 12.982 | 9.557 | 6.586 | 0 | 0 | 10.235 | 0.118 | 0.635 | 0 | 0 | 0 | 0 | 0 |
| Operating Expenses
| -1.506 | -0.117 | -0.644 | 3.337 | -26.444 | 12.227 | 16.083 | 4.403 | 15.716 | 15.625 | 22.078 | 22.388 | 24.705 | 25.104 | 24.775 | 25.622 | 24.126 | 24.176 | 17.301 | 18.208 | 15.389 | 28.843 | 12.174 | 8.47 |
| Operating Income
| -0.272 | 0.489 | 0.301 | -0.575 | 35.686 | -12.936 | -17.171 | -5.272 | 16.824 | -20.461 | 14.928 | -38.63 | -29.9 | -27.089 | -27.3 | -27.833 | -28.006 | -26.262 | -19.465 | -17.6 | -17.671 | -31.164 | -13.875 | -9.859 |
| Operating Income Ratio
| -0.038 | 0.093 | 0.073 | -0.159 | -4.738 | -2.47 | -3.247 | -4.245 | 3.391 | -5.615 | 3.662 | -10.494 | -6.855 | -5.888 | -5.797 | -7.751 | -10.88 | -8.277 | -17.165 | -11.118 | -26.414 | -48.241 | -18.903 | -12.527 |
| Total Other Income Expenses Net
| -1.031 | -1.305 | -0.663 | -1.48 | 0.279 | -0.226 | -15.286 | 0.992 | -1.634 | 0.036 | -9.21 | -1.387 | -1.364 | -1.422 | -1.427 | -1.348 | -1.373 | -5.026 | -3.728 | -0.498 | -3.029 | -0.921 | -16.47 | -4.836 |
| Income Before Tax
| -1.303 | -0.816 | -0.362 | -2.055 | 35.965 | -13.162 | -18.346 | -4.28 | 15.19 | -20.425 | 5.718 | -40.017 | -31.264 | -28.511 | -28.727 | -29.181 | -29.379 | -31.288 | -23.193 | -18.098 | -19.914 | -32.085 | -30.345 | -14.695 |
| Income Before Tax Ratio
| -0.183 | -0.155 | -0.088 | -0.567 | -4.775 | -2.513 | -3.469 | -3.446 | 3.061 | -5.605 | 1.403 | -10.871 | -7.167 | -6.197 | -6.1 | -8.126 | -11.414 | -9.861 | -20.452 | -11.433 | -29.767 | -49.667 | -41.342 | -18.672 |
| Income Tax Expense
| -4.781 | 4.791 | 0 | -0.01 | -0.012 | 0.075 | 1.395 | 0 | 0.082 | -0.036 | 9.21 | 1.387 | 1.392 | 1.441 | 1.456 | 1.388 | 0.023 | 1.366 | 0.544 | 1.354 | 1.363 | 1.394 | 13.769 | 5.742 |
| Net Income
| -1.406 | -5.607 | -0.914 | -1.62 | -33.765 | -13.237 | -18.346 | -16.315 | 15.108 | -20.389 | -3.492 | -41.404 | -31.264 | -28.511 | -28.727 | -29.181 | -29.402 | -31.288 | -23.193 | -18.098 | -19.914 | -32.085 | -30.345 | -14.695 |
| Net Income Ratio
| -0.197 | -1.065 | -0.221 | -0.447 | 4.483 | -2.527 | -3.469 | -13.136 | 3.045 | -5.595 | -0.857 | -11.248 | -7.167 | -6.197 | -6.1 | -8.126 | -11.423 | -9.861 | -20.452 | -11.433 | -29.767 | -49.667 | -41.342 | -18.672 |
| EPS
| -0.045 | -0.19 | -0.031 | -0.055 | 0.26 | -0.452 | -0.632 | -0.57 | 0.531 | -0.72 | 0.16 | -1.423 | -1.118 | -0.936 | -1.02 | -1.041 | -1.05 | -1.95 | -0.94 | -1.05 | -1.15 | -1.86 | -1.76 | -0.85 |
| EPS Diluted
| -0.045 | -0.19 | -0.031 | -0.055 | 0.26 | -0.452 | -0.632 | -0.57 | 0.406 | -0.72 | 0.16 | -1.423 | -1.118 | -0.936 | -1.02 | -1.041 | -1.05 | -1.95 | -0.94 | -1.05 | -1.15 | -1.86 | -1.76 | -0.85 |
| EBITDA
| 0.322 | 0.836 | 1.404 | -0.313 | 32.423 | -12.936 | -16.632 | -2.716 | 18.155 | -17.374 | 8.907 | -36.719 | -28.185 | -25.277 | -25.7 | -26.212 | -26.65 | -26.262 | -19.465 | -18.836 | -15.758 | -29.874 | -13.3 | -9.292 |
| EBITDA Ratio
| 0.045 | 0.159 | 0.34 | -0.086 | -4.305 | -2.47 | -3.145 | -2.187 | 3.659 | -4.768 | 2.185 | -9.975 | -6.461 | -5.494 | -5.458 | -7.299 | -10.354 | -8.277 | -17.165 | -11.899 | -23.555 | -46.245 | -18.12 | -11.807 |